Clintabs [Clindamycin]

Clindamycin hydrochloride tablets. The first clindamycin available in an easy-to-swallow tablet form. Indicated for the treatment of susceptible skin infections, deep wounds, abscesses, osteomyelitis and dental infections in dogs.

Click here to order

 

Active Ingredients:

Each tablet contains: Clindamycin hydrochloride.

Use:

For therapy of wounds, abscesses and dental infections administer 2.5 - 15mg/lb body weight every 12 hours. For therapy of osteomyelitis administer 5 - 15mg/lb body weight every 12 hours. See package insert for complete product information.

Dosage and Administration

Canine Infected Wounds, Abscesses and Dental Infections

Oral: 2.5 mg/lb body weight every 12 hours. Duration: Treatment with clindamycin hydrochloride products may be continued up to a maximum of 28 days if clinical judgment indicates. Treatment of acute infections should not be continued for more than three or four days if no response to therapy is seen.

Dosage Schedule:

Tablets

Clintabs 25 mg, administer 1 tablet every 12 hours for each 10 pounds of body weight.

Clintabs 75 mg, administer 1 tablet every 12 hours for each 30 pounds of body weight.

Clintabs 150 mg, administer 1 tablet every 12 hours for each 60 pounds of body weight.

Canine Osteomyelitis

Oral: 5.0 mg/lb body weight every 12 hours. Duration: Treatment with Clintabs (clindamycin hydrochloride) Tablets is recommended for a minimum of 28 days. Treatment should not be continued for longer than 28 days if no response to therapy is seen.

Dosage Schedule:

Tablets

Clintabs 25 mg, administer 1 tablet every 12 hours for each 5 pounds of body weight.

Clintabs 75 mg, administer 1 tablet every 12 hours for each 15 pounds of body weight.

Clintabs 150 mg, administer 1 tablet every 12 hours for each 30 pounds of body weight.

 

Contra-indications

Clintabs (clindamycin hydrochloride) Tablets are contraindicated in animals with a history of hypersensitivity to preparations containing clindamycin or lincomycin.

Because of potential adverse gastrointestinal effects, do not administer to rabbits, hamsters, guinea pigs, horses, chinchillas or ruminating animals.

 

Pharmaceutial Precautions

Clintabs (clindamycin hydrochloride) Tablets should be prescribed with caution in atopic animals.

During prolonged therapy of one month or greater, periodic liver and kidney function tests and blood counts should be performed.

The use of clindamycin hydrochloride occasionally results in overgrowth of non-susceptible organisms such as clostridia and yeasts. Therefore, the administration of clindamycin hydrochloride should be avoided in those species sensitive to the gastrointestinal effects of clindamycin (see CONTRAINDICATIONS). Should superinfections occur, appropriate measures should be taken as indicated by the the clinical situation.

Patients with very severe renal disease and/or very severe hepatic disease accompanied by severe metabolic aberrations should be dosed with caution, and serum clindamycin levels monitored during high-dose therapy.

Clindamycin hydrochloride has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Therefore, clindamycin hydrochloride should be used with caution in animals receiving such agents.

Safety in gestating bitches or breeding males has not been established.

Store at controlled room temperature 20°-25°C (68°-77°F).

Keep container tightly closed.